https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ANiacin%2F58%2FenTranslations:Niacin/58/en - Revision history2026-11-12T19:07:00ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Niacin/58/en&diff=117758&oldid=prevFuzzyBot: Importing a new version from external source2024-02-20T00:42:52Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>Prescription niacin preparations in combination with statin drugs (discontinued) are described above. A combination of niacin and [[laropiprant]] had been approved for use in Europe and marketed as Tredaptive. Laropiprant is a [[prostaglandin D2]] binding drug shown to reduce niacin-induced vasodilation and flushing side effects. A clinical trial showed no additional efficacy of Tredaptive in lowering cholesterol when used together with other statin drugs, but did show an increase in other side effects. The study resulted in the withdrawal of Tredaptive from the international market.</div>FuzzyBot